Early Phase 1 Toxicity Clinical Trials
3 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy
Immune Effector Cell Associated Hematotoxicity
Institute of Hematology & Blood Diseases Hospital, China15 enrolled1 locationNCT07212335
Recruiting
Early Phase 1
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
Prostate CancerRadiation ToxicityUrinary Complication
University of Rochester30 enrolled1 locationNCT05530655
Recruiting
Early Phase 1
Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaHepatotoxicity
Children's Hospital of Orange County20 enrolled2 locationsNCT05501899